Mancia et al. (2020) conducted a case-control study in the Lombardy...

Mancia et al. (2020) conducted a case-control study in the Lombardy region of Italy to examine the association between the use of angiotensin-converting-enzyme (ACE) inhibitors and the odds of coronavirus disease 2019 (COVID-19). There were 1,502 COVID-19 cases among the 8,071 patients who used ACE inhibitors. There were 4,770 COVID-19 cases among the 28,960 patients who did not use ACE inhibitors. Using a 0.05 significance level, you need to test the claim that the proportion of COVID-19 patients among those who used ACE inhibitors (group 1) is higher than the proportion of COVID-19 patients among those who did not use ACE inhibitors (group 2). To do so, answer each of the following questions.

What conclusion should you make based on the given data? (1 point)

Select one:

a. Fail to reject H0 and conclude there is sufficient evidence to support the claim that the proportion of COVD-19 cases is higher among those who used ACE inhibitors than those who did not use ACE inhibitors.

b. Fail to reject H0 and conclude there is not sufficient evidence to support the claim that the proportion of COVD-19 cases is higher among those who used ACE inhibitors than those who did not use ACE inhibitors.

c. Accept H0 and conclude there is sufficient evidence to support the claim that the proportion of COVD-19 cases is higher among those who used ACE inhibitors than those who did not use ACE inhibitors.

d. Reject H0 and conclude there is sufficient evidence to support the claim that the proportion of COVD-19 cases is higher among those who used ACE inhibitors than those who did not use ACE inhibitors.

e. Reject H0 and conclude there is not sufficient evidence to support the claim that the proportion of COVD-19 cases is higher among those who used ACE inhibitors than those who did not use ACE inhibitors.